Globalpharma - a Sanofi company becoming a leading generics partner in the region
Globalpharma was established in 1998 and is based in Dubai Investment Park. The manufacturing facility covers an area of 27.000 m2 and the annual capacity of the plant includes the production of 300 million tablets, 150 million capsules, and over 7 million litres of dry syrup and liquid.
Following the completion of the acquisition of a significant stake, announced in 2014, Globalpharma is being integrated as a Sanofi company to become the platform to manufacture and promote the generics portfolio of Sanofi in Middle East markets. Through a transfer of technology, Sanofi aims to strengthen the local industry and implement first-in-class technology procedures to establish and grow generic presence in the Middle East.
Globalpharma products are currently registered in the GCC (Gulf Cooperation Council) and other Middle East markets, with registration underway in other neighbouring markets. The manufacturing facility was accredited by the regulatory authorities in the GCC including UAE MOH (Ministry of Health), SFDA (Saudi Food and Drug Administration), Oman MOH and the central GCC Secretariat.